3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
2
Colorectal Neoplasms
2
Prostatic Neoplasms
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Lobular
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
4
aldesleukin
3
Cisplatin
3
lenvatinib
2
Surveys and Questionnaires
2
Specimen Handling
2
Paclitaxel
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Adoptive Transfer
2
zimberelimab
1
trastuzumab deruxtecan
1
tivozanib
1
liposomal doxorubicin
1
fludarabine phosphate
1
fludarabine
1
entinostat
1
dostarlimab
1
cemiplimab
1
bintrafusp alfa protein, human
1
belzutifan
1
atezolizumab
1
Therapeutic Touch
1
Taxes
1
Standard of Care
1
Sonazoid
1
Respiratory Function Tests
1
Radiotherapy
1
Radiation
1
Prochlorperazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Vulvar Neoplasms
×
Gene Expression Profiling
×
1 year
×
Clear all
No trials found.